{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:14:06Z","timestamp":1793783646364,"version":"4.6.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["23FC1032"],"award-info":[{"award-number":["23FC1032"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recently, Newborn screening (NBS) has been expanded worldwide to include lysosomal storage diseases (LSDs) and adrenoleukodystrophy (ALD) due to the importance of early diagnosis and early treatment. In Japan, NBS for LSDs, termed expanded NBS, was first implemented in Kumamoto prefecture in 2006 as pilot study. NBS for ALD was subsequently introduced in Aichi prefecture and Gifu prefecture in 2021. Expanded NBS for LSDs and ALD has become more widespread in Japan. In light of this current situation, we considered it is necessary to clarify the usefulness of expanded NBS, prevalence of each disease, challenges encountered. Therefore, we reported the current implementation status of expanded NBS in Japan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A survey was conducted among physicians responsible for expanded NBS in each target region Japan. The target regions were those that implemented NBS for LSDs and\/or ALD for more than one year. The survey items included: the entity conducting expanded NBS, the facilities conducting the tests, the target areas, medical institutions for close examination such as detailed biochemical analysis and\/or genetic sequencing, and treatments, types of target diseases, fee for NBS, sample collection methods, testing method, and quantitative data on expanded NBS, retesting, and diagnoses in each area.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Responses were received from nine regions and an organization (CReARID). The total number of 733,838 newborns were screening, with 101 diagnoses: 75 cases of Fabry disease, 10 of mucopolysaccharidosis (MPS) II, 8 of Pompe disease, 5 of Gaucher disease, 2 of MPS I, 1 of ALD, respectively) were diagnosed. More cases were diagnosed with the target disease than the estimated prevalence. In contrast, the positive predictive value was low and false-positive rates was elevated, particularly for PD, MPS II, and ALD, have been attributed to pseudodeficiency alleles and methodological differences. Moreover, variant of unknown significance (VUS) in the\n                      <jats:italic>ABCD1<\/jats:italic>\n                      gene was detected in many of the patients with suspected ALD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In Japan, Expanded NBS for LSDs and ALD has become more widespread. Since its implementation, some patients have been diagnosed and received treatment. However, challenges such as pseudodeficiency, indications, testing methods, and VUS that require improvement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03848-4","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T06:34:23Z","timestamp":1753338863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Japanese experience of newborn screening for lysosomal storage diseases and adrenoleukodystrophy"],"prefix":"10.1186","volume":"20","author":[{"given":"Takanori","family":"Onuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Tajika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ichimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toju","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Nyuzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motomichi","family":"Kosuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohsuke","family":"Migita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Sasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpei","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimitoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torayuki","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3923-8636","authenticated-orcid":false,"given":"Kei","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"issue":"3","key":"3848_CR1","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.cell.2020.01.017","volume":"180","author":"JA Martina","year":"2020","unstructured":"Martina JA, Raben N, Puertollano R. SnapShot: lysosomal storage diseases. Cell. 2020;180(3):602-602.e1. https:\/\/doi.org\/10.1016\/j.cell.2020.01.017.","journal-title":"Cell"},{"issue":"9","key":"3848_CR2","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1080\/14712598.2022.2124857","volume":"22","author":"AO Gupta","year":"2022","unstructured":"Gupta AO, Raymond G, Pierpont EI, Kemp S, McIvor RS, Rayannavar A, Miller B, Lund TC, Orchard PJ. Treatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy. Expert Opin Biol Ther. 2022;22(9):1151\u201362. https:\/\/doi.org\/10.1080\/14712598.2022.2124857.","journal-title":"Expert Opin Biol Ther"},{"issue":"6148","key":"3848_CR3","doi-asserted-by":"publisher","first-page":"1233158","DOI":"10.1126\/science.1233158","volume":"341","author":"A Biffi","year":"2013","unstructured":"Biffi A, Montini E, Lorioli L, et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science. 2013;341(6148):1233158. https:\/\/doi.org\/10.1126\/science.1233158.","journal-title":"Science"},{"issue":"4","key":"3848_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2023.107734","volume":"140","author":"C Videb\u00e6k","year":"2023","unstructured":"Videb\u00e6k C, Melgaard L, Lund AM, Gr\u00f8nborg SW. Newborn screening for adrenoleukodystrophy: International experiences and challenges. Mol Genet Metab. 2023;140(4): 107734. https:\/\/doi.org\/10.1016\/j.ymgme.2023.107734.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"3848_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1210\/endrev\/bnaa013","volume":"41","author":"J Zhu","year":"2020","unstructured":"Zhu J, Eichler F, Biffi A, Duncan CN, Williams DA, Majzoub JA. The changing face of adrenoleukodystrophy. Endocr Rev. 2020;41(4):577\u201393. https:\/\/doi.org\/10.1210\/endrev\/bnaa013.","journal-title":"Endocr Rev"},{"issue":"5","key":"3848_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.10754","volume":"7","author":"S Chang","year":"2024","unstructured":"Chang S, Zhan X, Liu Y, et al. Newborn screening for 6 lysosomal storage disorders in China. JAMA Netw Open. 2024;7(5): e2410754. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.10754.","journal-title":"JAMA Netw Open"},{"key":"3848_CR7","doi-asserted-by":"publisher","unstructured":"American College of Medical Genetics Newborn Screening Expert Group. Newborn screening: toward a uniform screening panel and system--executive summary. Pediatrics. 2006; 117(5 Pt 2):S296\u2013307. https:\/\/doi.org\/10.1542\/peds.2005-2633I.","DOI":"10.1542\/peds.2005-2633I"},{"issue":"1","key":"3848_CR8","first-page":"25","volume":"126","author":"Go Tajima","year":"2022","unstructured":"Tajima Go, Koremura K. Expansion of target diseases for neonatal screening in Japan and in foreign countries. J Jpn Pediatr Soc. 2022;126(1):25\u201334 ((in Japanese)).","journal-title":"J Jpn Pediatr Soc"},{"issue":"22","key":"3848_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2019.100562","volume":"11","author":"T Sawada","year":"2020","unstructured":"Sawada T, Kido J, Yoshida S, Sugawara K, Momosaki K, Inoue T, Tajima G, Sawada H, Mastumoto S, Endo F, Hirose S, Nakamura K. Newborn screening for Fabry disease in the western region of Japan. Mol Genet Metab Rep. 2020;11(22): 100562. https:\/\/doi.org\/10.1016\/j.ymgmr.2019.100562.","journal-title":"Mol Genet Metab Rep"},{"issue":"1","key":"3848_CR10","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s13023-021-02146-z","volume":"16","author":"T Sawada","year":"2021","unstructured":"Sawada T, Kido J, Sugawara K, Momosaki K, Yoshida S, Kojima-Ishii K, Inoue T, Matsumoto S, Endo F, Ohga S, Hirose S, Nakamura K. Current status of newborn screening for Pompe disease in Japan. Orphanet J Rare Dis. 2021;16(1):516. https:\/\/doi.org\/10.1186\/s13023-021-02146-z.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3848_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/ijns7030058","volume":"7","author":"N Shimozawa","year":"2021","unstructured":"Shimozawa N, Takashima S, Kawai H, Kubota K, Sasai H, Orii K, Ogawa M, Ohnishi H. Advanced diagnostic system and introduction of newborn screening of adrenoleukodystrophy and peroxisomal disorders in Japan. Int J Neonatal Screen. 2021;7(3):58. https:\/\/doi.org\/10.3390\/ijns7030058.","journal-title":"Int J Neonatal Screen"},{"issue":"8","key":"3848_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s10038-019-0603-7","volume":"64","author":"K Momosaki","year":"2019","unstructured":"Momosaki K, Kido J, Yoshida S, Sugawara K, Miyamoto T, Inoue T, Okumiya T, Matsumoto S, Endo F, Hirose S, Nakamura K. Newborn screening for Pompe disease in Japan: report and literature review of mutations in the GAA gene in Japanese and Asian patients. J Hum Genet. 2019;64(8):741\u201355. https:\/\/doi.org\/10.1038\/s10038-019-0603-7.","journal-title":"J Hum Genet"},{"issue":"3","key":"3848_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ymgme.2021.05.004","volume":"133","author":"Y Koto","year":"2021","unstructured":"Koto Y, Sakai N, Lee Y, Kakee N, Matsuda J, Tsuboi K, Shimozawa N, Okuyama T, Nakamura K, Narita A, Kobayashi H, Uehara R, Nakamura Y, Kato K, Eto Y. Prevalence of patients with lysosomal storage disorders and peroxisomal disorders: A nationwide survey in Japan. Mol Genet Metab. 2021;133(3):277\u201388. https:\/\/doi.org\/10.1016\/j.ymgme.2021.05.004.","journal-title":"Mol Genet Metab"},{"issue":"37","key":"3848_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2023.101003","volume":"28","author":"Y Hattori","year":"2023","unstructured":"Hattori Y, Sawada T, Kido J, Sugawara K, Yoshida S, Matsumoto S, Inoue T, Hirose S, Nakamura K. Frequency of iduronate-2-sulfatase gene variants detected in newborn screening for mucopolysaccharidosis type II in Japan. Mol Genet Metab Rep. 2023;28(37): 101003. https:\/\/doi.org\/10.1016\/j.ymgmr.2023.101003.","journal-title":"Mol Genet Metab Rep"},{"issue":"31","key":"3848_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2022.100850","volume":"18","author":"T Sawada","year":"2022","unstructured":"Sawada T, Kido J, Sugawara K, Yoshida S, Matsumoto S, Shimazu T, Matsushita Y, Inoue T, Hirose S, Endo F, Nakamura K. Newborn screening for Gaucher disease in Japan. Mol Genet Metab Rep. 2022;18(31): 100850. https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100850.","journal-title":"Mol Genet Metab Rep"},{"issue":"8","key":"3848_CR16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/jhg.2013.48","volume":"58","author":"T Inoue","year":"2013","unstructured":"Inoue T, Hattori K, Ihara K, Ishii A, Nakamura K, Hirose S. Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study. J Hum Genet. 2013;58(8):548\u201352. https:\/\/doi.org\/10.1038\/jhg.2013.48.","journal-title":"J Hum Genet"},{"issue":"1\u20132","key":"3848_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ymgme.2022.07.010","volume":"137","author":"DP Germain","year":"2022","unstructured":"Germain DP, Altarescu G, Barriales-Villa R, Mignani R, Pawlaczyk K, Pieruzzi F, Terryn W, Vujkovac B, Ortiz A. An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease. Mol Genet Metab. 2022;137(1\u20132):49\u201361. https:\/\/doi.org\/10.1016\/j.ymgme.2022.07.010.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"3848_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/ijns10010003","volume":"10","author":"V Gragnaniello","year":"2023","unstructured":"Gragnaniello V, Cazzorla C, Gueraldi D, Puma A, Loro C, Porc\u00f9 E, Stornaiuolo M, Miglioranza P, Salviati L, Burlina AP, Burlina AB. Light and shadows in newborn screening for lysosomal storage disorders: eight years of experience in Northeast Italy. Int J Neonatal Screen. 2023;10(1):3. https:\/\/doi.org\/10.3390\/ijns10010003.","journal-title":"Int J Neonatal Screen"},{"issue":"1\u20132","key":"3848_CR19","doi-asserted-by":"publisher","first-page":"107654","DOI":"10.1016\/j.ymgme.2023.107654","volume":"140","author":"F Kubaski","year":"2023","unstructured":"Kubaski F, Sousa I, Amorim T, Pereira D, Silva C, Chaves V, Brusius-Facchin AC, Netto ABO, Soares J, Vairo F, Poletto E, Trometer J, Souza A, Ranieri E, Polo G, Hong X, Herbst ZM, Burlina A, Gelb MH, Giugliani R. Pilot study of newborn screening for six lysosomal diseases in Brazil. Mol Genet Metab. 2023;140(1\u20132):107654. https:\/\/doi.org\/10.1016\/j.ymgme.2023.107654.","journal-title":"Mol Genet Metab"},{"issue":"8","key":"3848_CR20","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/gim.2017.190","volume":"20","author":"S Tortorelli","year":"2018","unstructured":"Tortorelli S, Eckerman JS, Orsini JJ, Stevens C, Hart J, Hall PL, Alexander JJ, Gavrilov D, Oglesbee D, Raymond K, Matern D, Rinaldo P. Moonlighting newborn screening markers: the incidental discovery of a second-tier test for Pompe disease. Genet Med. 2018;20(8):840\u20136. https:\/\/doi.org\/10.1038\/gim.2017.190.","journal-title":"Genet Med"},{"issue":"3","key":"3848_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijns4030024","volume":"4","author":"DS Millington","year":"2018","unstructured":"Millington DS, Bali DS. Current state of the art of newborn screening for lysosomal storage disorders. Int J Neonatal Screen. 2018;4(3):24. https:\/\/doi.org\/10.3390\/ijns4030024.","journal-title":"Int J Neonatal Screen"},{"issue":"13","key":"3848_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.21037\/atm.2019.05.47","volume":"7","author":"YH Chien","year":"2019","unstructured":"Chien YH, Hwu WL, Lee NC. Newborn screening: Taiwanese experience. Ann Transl Med. 2019;7(13):281. https:\/\/doi.org\/10.21037\/atm.2019.05.47.","journal-title":"Ann Transl Med"},{"key":"3848_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jpeds.2018.09.063","volume":"205","author":"MJ Chan","year":"2019","unstructured":"Chan MJ, Liao HC, Gelb MH, et al. Taiwan national newborn screening program by tandem mass spectrometry for mucopolysaccharidoses Types I, II, and VI. J Pediatr. 2019;205:176\u201382. https:\/\/doi.org\/10.1016\/j.jpeds.2018.09.063.","journal-title":"J Pediatr"},{"issue":"2","key":"3848_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ymgme.2020.03.004","volume":"130","author":"SA Khan","year":"2020","unstructured":"Khan SA, Mason RW, Kobayashi H, Yamaguchi S, Tomatsu S. Advances in glycosaminoglycan detection. Mol Genet Metab. 2020;130(2):101\u20139. https:\/\/doi.org\/10.1016\/j.ymgme.2020.03.004.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"3848_CR25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ymgme.2012.09.024","volume":"107","author":"J de Ruijter","year":"2012","unstructured":"de Ruijter J, de Ru MH, Wagemans T, Ijlst L, Lund AM, Orchard PJ, Schaefer GB, Wijburg FA, van Vlies N. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I. II and III Mol Genet Metab. 2012;107(4):705\u201310. https:\/\/doi.org\/10.1016\/j.ymgme.2012.09.024.","journal-title":"II and III Mol Genet Metab"},{"key":"3848_CR26","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/diagnostics11081347","volume":"11","author":"N Arunkumar","year":"2021","unstructured":"Arunkumar N, Vu DC, Khan S, Kobayashi H, Ngoc Can TB, Oguni T, Watanabe J, Tanaka M, Yamaguchi S, Taketani T, et al. Diagnosis of mucopolysaccharidoses and mucolipidosis by assaying multiplex enzymes and glycosaminoglycans. Diagnostics. 2021;11:1347. https:\/\/doi.org\/10.3390\/diagnostics11081347.","journal-title":"Diagnostics"},{"issue":"4","key":"3848_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/ijns10040071","volume":"10","author":"O Ayodele","year":"2024","unstructured":"Ayodele O, Fertek D, Evuarherhe O, Siffel C, Audi J, Yee KS, Burton BK. A systematic literature review on the global status of newborn screening for mucopolysaccharidosis II. Int J Neonatal Screen. 2024;10(4):71. https:\/\/doi.org\/10.3390\/ijns10040071.","journal-title":"Int J Neonatal Screen"},{"issue":"1","key":"3848_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13023-024-03195-w","volume":"19","author":"JW Li","year":"2024","unstructured":"Li JW, Mao SJ, Chao YQ, Hu CX, Qian YJ, Dai YL, Huang K, Shen Z, Zou CC. Application of tandem mass spectrometry in the screening and diagnosis of mucopolysaccharidoses. Orphanet J Rare Dis. 2024;19(1):179. https:\/\/doi.org\/10.1186\/s13023-024-03195-w.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3848_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijns5010001","volume":"5","author":"MH Gelb","year":"2019","unstructured":"Gelb MH, Lukacs Z, Ranieri E, Schielen PCJI. Newborn screening for lysosomal storage disorders: methodologies for measurement of enzymatic activities in dried blood spots. Int J Neonatal Screen. 2019;5(1):1. https:\/\/doi.org\/10.3390\/ijns5010001.","journal-title":"Int J Neonatal Screen"},{"issue":"4","key":"3848_CR30","first-page":"281","volume":"65","author":"JM Wilson","year":"1968","unstructured":"Wilson JM, Jungner YG. Principles and practice of mass screening for disease. Bol Oficina Sanit Panam. 1968;65(4):281\u2013393.","journal-title":"Bol Oficina Sanit Panam"},{"issue":"1","key":"3848_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/gim.2016.68","volume":"19","author":"AR Kemper","year":"2017","unstructured":"Kemper AR, Brosco J, Comeau AM, Green NS, Grosse SD, Jones E, Kwon JM, Lam WK, Ojodu J, Prosser LA, Tanksley S. Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation. Genet Med. 2017;19(1):121\u20136. https:\/\/doi.org\/10.1038\/gim.2016.68.","journal-title":"Genet Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03848-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03848-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03848-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T06:34:24Z","timestamp":1753338864000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03848-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3848"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03848-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical principles of this study were conducted in accordance with the guidelines of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"373"}}